Investment Type: Venture Capital
Investment Stage: Series A
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 11.04.2018 | RubrYc | rubryc.com | $10M | - |
Mentions in press and media 8
| Date | Title | Description |
| 06.10.2021 | Starting a health technology company in Baltimore? Here are 43 resources to know | The digital health sector was growing rapidly. Then the pandemic came. In this case, it was a story of growth. Following distancing requirements and loosening regulations, telemedicine became the name of the game for many healthcare systems... |
| 16.10.2020 | Need startup funding? Here are 75+ venture capital firms in the Baltimore-DC region | If you’re located in New York City or the Silicon Valley, venture capital firms are abundant and well covered by the media — you can’t escape them. But entrepreneurs in the Baltimore-D.C. region don’t need to go so far to find a firm that c... |
| 13.10.2020 | Need startup funding? Here are 75+ venture capital firms in the DMV region | If you’re located in New York City or the Silicon Valley, venture capital firms are abundant and well covered by the media — you can’t escape them. But entrepreneurs in the DMV region don’t need to go so far to find a firm that could propel... |
| 15.04.2018 | Paladin Capital Joins $10M Series A for RubrYc Therapeutics | RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventures, with participation by Paladin Capital Group and Vital Ventur... |
| 15.04.2018 | Paladin Capital Joins $10M Series A for RubrYc Therapeutics | RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventures, with participation by Paladin Capital Group and Vital Ventur... |
| 15.04.2018 | Vital Venture Joins $10M Series A for RubrYc Therapeutics | RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventures, with participation by Paladin Capital Group and Vital Ventur... |
| 15.04.2018 | Vital Venture Joins $10M Series A for RubrYc Therapeutics | RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventures, with participation by Paladin Capital Group and Vital Ventur... |
| 08.10.2013 | AxioMx Completes $2M Second Financing Round | AxioMx Inc., a Branford, Connecticut-based early-stage biotechnology company that offers a full range of custom antibody discovery and development services for the research, diagnostic and therapeutic marketplaces, completed a $2m second fi... |